SubHero Banner
Text

Truvada® (emtricitabine/tenofovir disoproxil fumarate) and Atripla® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) – First-time generics

October 2, 2020 - Teva Pharmaceuticals launched AB-rated generic versions of Gilead’s Truvada (emtricitabine [FTC]/tenofovir disoproxil fumarate [TDF]) 200 mg/300 mg tablets and Atripla (efavirenz/FTC/TDF) tablets.

Download PDF